Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Tel Aviv
SEC filing record 1 source field available
Fiscal year end
31 December
TEVA PHARMACEUTICAL INDUSTRIES LTD has filed 2,531 SEC EDGAR filings since 02 Feb 1996

SEC filing history

Showing 76-100 of 709 matching filings.

Per page
25
Current page
4
6-K File 001-16174

LIVE FILING

Filing date
28 Feb 2017
Reporting date
28 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-16174

FORM 6-K

Filing date
16 Feb 2017
Reporting date
15 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-16174

TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K

Filing date
13 Feb 2017
Reporting date
13 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-16174

LIVE FILING

Filing date
06 Feb 2017
Reporting date
06 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-16174

LIVE FILING

Filing date
02 Feb 2017
Reporting date
02 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-16174

LIVE FILING

Filing date
01 Feb 2017
Reporting date
01 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-16174

LIVE FILING

Filing date
31 Jan 2017
Reporting date
31 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-16174

LIVE FILING

Filing date
30 Jan 2017
Reporting date
30 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-16174

LIVE FILING

Filing date
26 Jan 2017
Reporting date
26 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-16174

LIVE FILING

Filing date
18 Jan 2017
Reporting date
18 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-16174

LIVE FILING

Filing date
09 Jan 2017
Reporting date
09 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-16174

LIVE FILING

Filing date
06 Jan 2017
Reporting date
06 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-16174

TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K

Filing date
06 Jan 2017
Reporting date
06 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-16174

LIVE FILING

Filing date
05 Jan 2017
Reporting date
05 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-16174

LIVE FILING

Filing date
22 Dec 2016
Reporting date
22 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-16174

LIVE FILING

Filing date
07 Dec 2016
Reporting date
07 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-16174

LIVE FILING

Filing date
06 Dec 2016
Reporting date
06 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-16174

LIVE FILING

Filing date
06 Dec 2016
Reporting date
06 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-16174

LIVE FILING

Filing date
05 Dec 2016
Reporting date
05 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-16174

LIVE FILING

Filing date
30 Nov 2016
Reporting date
30 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-16174

LIVE FILING

Filing date
21 Nov 2016
Reporting date
21 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-16174

TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K

Filing date
15 Nov 2016
Reporting date
15 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-16174

LIVE FILING

Filing date
08 Nov 2016
Reporting date
08 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-16174

LIVE FILING

Filing date
07 Nov 2016
Reporting date
07 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .